4.7 Article

Candidate driver genes in microsatellite-unstable colorectal cancer

期刊

INTERNATIONAL JOURNAL OF CANCER
卷 130, 期 7, 页码 1558-1566

出版社

WILEY-BLACKWELL
DOI: 10.1002/ijc.26167

关键词

microsatellite instability; colorectal cancer; frameshift mutation

类别

资金

  1. Academy of Finland
  2. Finnish Cancer Society
  3. Sigrid Juselius Foundation
  4. Association for International Cancer Research
  5. Helsinki University
  6. Biocentrum Helsinki
  7. European Commission
  8. Orion-Farmos Research Foundation
  9. AstraZeneca
  10. Finnish Medical Society
  11. Lilly Foundation
  12. Finnish Gastroenterology and Oncology Society
  13. Biomedicum Helsinki Foundation
  14. Paulo Foundation
  15. Maud Kuistila Foundation
  16. Ida Montin Foundation

向作者/读者索取更多资源

Defects in the mismatch repair system lead to microsatellite instability (MSI), a feature observed in similar to 15% of all colorectal cancers (CRCs). Microsatellite mutations that drive tumourigenesis, typically inactivation of tumour suppressors, are selected for and are frequently detected in MSI cancers. Here, we evaluated somatic mutations in microsatellite repeats of 790 genes chosen based on reduced expression in MSI CRC and existence of a coding mononucleotide repeat of 6 similar to 10 bp in length. All the repeats were initially sequenced in 30 primary MSI CRC samples and whenever frameshift mutations were identified in >20%, additional 70 samples were sequenced. To distinguish driver mutations from passengers, we similarly analyzed the occurrence of frameshift mutations in 121 intronic control repeats and utilized a statistical regression model to determine cut-off mutation frequencies for repeats of all types (A/T and C/G, 610 bp). Along with several know target genes, including TGFBR2, ACVR2, and MSH3, six novel candidate driver genes emerged that harbored significantly more mutations than identical control repeats. The mutation frequencies in 100 MSI CRC samples were 51% in G8 of GLYR1, 47% in T9 of ABCC5, 43% in G8 of WDTC1, 33% in A8 of ROCK1, 30% in T8 of OR51E2, and 28% in A8 of TCEB3. Immunohistochemical staining of GLYR1 revealed defective protein expression in tumors carrying biallelic mutations, supporting a loss of function hypothesis. This is a large scale, unbiased effort to identify genes that when mutated are likely to contribute to MSI CRC development.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据